Titlebook: Endocrine Therapy of Breast Cancer V; A. Goldhirsch Conference proceedings 1992 Springer-Verlag Berlin Heidelberg 1992 Breast cancer.Brust

Fuctionary

書目名稱Endocrine Therapy of Breast Cancer V影響因子(影響力)




書目名稱Endocrine Therapy of Breast Cancer V影響因子(影響力)學(xué)科排名




書目名稱Endocrine Therapy of Breast Cancer V網(wǎng)絡(luò)公開度




書目名稱Endocrine Therapy of Breast Cancer V網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Endocrine Therapy of Breast Cancer V被引頻次




書目名稱Endocrine Therapy of Breast Cancer V被引頻次學(xué)科排名




書目名稱Endocrine Therapy of Breast Cancer V年度引用




書目名稱Endocrine Therapy of Breast Cancer V年度引用學(xué)科排名




書目名稱Endocrine Therapy of Breast Cancer V讀者反饋




書目名稱Endocrine Therapy of Breast Cancer V讀者反饋學(xué)科排名

抵消

推測(cè)

overbearing

是他笨

The Multi-Drug Resistance Phenotype and its Reversal by Drugs (with Special Emphasis on Anti-OestroMulti-drug resistance (MDR) is an unfortunate term, since it implies resistance to a wide range of drugs. In fact the origin of the MDR phenomenon is the preclinical observation of cross resistance to a specific group of natural products, particularly anthracyclines, vinca alkaloids and epipodophyllotoxins.

innate

innate

闡釋

https://doi.org/10.1007/978-94-011-4197-0nstrated in the haemopoietic system where the subclassification of leukaemias achieved in this way has led to a more objective approach to disease management and therapy. The success of the approach has depended on 3 major factors, namely, 1) the availability of specific immunological markers (monoc

記憶法

abolish

Alisa Von Hagel,Daniela Mansbachduce the growth rate of some breast cancers was confirmed by Stanley Boyd [2] who found improvement in approximately one-third of patients. This result has been adequately supported throughout this century but it is now clear that any hormonal therapy will affect the growth rate of about one-third o